Page last updated: 2024-09-04

butylscopolammonium bromide and Acute Pain

butylscopolammonium bromide has been researched along with Acute Pain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Scharonow, M; Scharonow, O; Vilcane, S; Weilbach, C1
Du, YQ; Guo, XZ; Hou, XH; Jiang, F; Li, ZS; Wang, RQ; Xu, H; Zeng, Y; Zhu, CP1

Trials

1 trial(s) available for butylscopolammonium bromide and Acute Pain

ArticleYear
Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm-like pain: A randomized, double-blinded, multicenter Phase III trial.
    Journal of digestive diseases, 2017, Volume: 18, Issue:8

    Topics: Abdominal Pain; Acute Pain; Adult; Butylscopolammonium Bromide; Colic; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Solanaceous Alkaloids; Spasm; Treatment Outcome

2017

Other Studies

1 other study(ies) available for butylscopolammonium bromide and Acute Pain

ArticleYear
Application of analgesics in emergency services in Germany: a survey of the medical directors.
    BMC emergency medicine, 2023, 09-14, Volume: 23, Issue:1

    Topics: Acetaminophen; Acute Pain; Adult; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Butylscopolammonium Bromide; Dipyrone; Fentanyl; Germany; Humans; Ketamine; Morphine Derivatives; Nalbuphine; Physician Executives; Pirinitramide

2023